Replies to post #764284 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

x,

Thanks for your keen insights about combos 😶

For DCVax-L, there are two combo trials that are particularly relevant today:

⭐️You will be pleased to notice placebo-controlled RCTs on the list!⭐️

☑️ Completed Hiltonol (poly-ICLC) Trial:
https://clinicaltrials.gov/study/NCT01204684

☑️ Ongoing Hiltonol (poly-ICLC) Trial:
https://www.clinicaltrials.gov/study/NCT04201873

The research at Roswell was recently approved to expand … Two of their DC combo trials are particularly noteworthy—active, grant-funded, and posted recent updates!

☑️ https://clinicaltrials.gov/study/NCT04348747?a=29&b=30

☑️ https://clinicaltrials.gov/study/NCT04093323

There are other P1 or P2 studies too at Moffitt that seem to overlap with Roswell, and Moffitt has a couple additional studies that will soon be recruiting… We may soon hear more about Roswell’s collaboration with Moffitt which could be very significant news, imo.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176090178

Among the listed Moffitt dendritic cell trials (that are active now), Roswell is included/mentioned! One study involves an interesting DC combo with adoptive T Cell therapy! All four trials appear to be active with recently posted updates on clinicaltrials.gov:


https://clinicaltrials.gov/study/NCT05325632



https://clinicaltrials.gov/study/NCT04348747
(Roswell trial listed on Moffitt website and has Moffitt in Florida as one of the study locations)



https://clinicaltrials.gov/study/NCT05809752
(Moffitt trial with planned study location at Roswell)



https://clinicaltrials.gov/study/NCT05378464

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176090178

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175935295












“They called me Gabagool Research”



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176114523